The development of anti-infective treatments to combat illnesses caused by viral and microbial agents has witnessed many unique advances, most notably in the
fights against bacterial infections, hepatitis and HIV. The momentum in this exciting area continues with new tools and methods to better support the development journey. From improved microbial identification to quantitative technological platforms, let’s explore emerging opportunities to develop assays, interpret results and improve clinical trials.
Learn how novel technologies and analytical techniques are accelerating discoveries and transforming results in infectious disease drug development. Download our new infectious disease eBook today.